Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
Lancet. 1998 Nov 7; 352(9139):1491-7. PMID: 9820296.Abstract